Maprimed Sa, based in Argentina, is a pharmaceutical company.
One of their notable products is FLECAINIDE ACETATE PROCESS III (CODE 50970), with a corresponding US DMF Number 28158.
Remarkably, this DMF maintains an Active status since its submission on May 15, 2014, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 22, 2014, and payment made on April 28, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II